Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salsalate vs Placebo in Osteoarthritis With Nonalcoholic Fatty Liver Disease
NCT03222206Phase 4Completed
- Sponsor
- Korea University Guro Hospital
- Start
- Nov 2017
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in non-alcoholic fatty liver disease (NAFLD) and osteoarthritis (OA) comparing Salsalate with Placebo (2 arms). Primary endpoints: Controlled Attenuation Parameter at 8 weeks, Fetuin-A at 8 weeks and 2 more. Started Nov 2017; status: completed.
02
Drugs
Amigesic
03
Conditions
non-alcoholic fatty liver disease (NAFLD)osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03222206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03222206.